Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Academy Sports and Outdoors | ASO | Mar 28, 2024 | 67.54 | -0.53 |
Acadia Healthcare | ACHC | Mar 28, 2024 | 79.22 | +1.12 |
Acadia Pharmaceuticals | ACAD | Mar 28, 2024 | 18.49 | +1.59 |
Acadia Realty Trust | AKR | Mar 28, 2024 | 17.01 | +1.86 |
Acasti Pharma A | ACST | Mar 28, 2024 | 3.42 | +0.74 |
Accel Entertainment | ACEL | Mar 28, 2024 | 11.79 | +0.17 |
Accelerate Diagnostics | AXDX | Mar 28, 2024 | 0.99 | -1.98 |
Accenture A | ACN | Mar 28, 2024 | 346.61 | +1.66 |
Acco Brands | ACCO | Mar 28, 2024 | 5.61 | -0.18 |
Accolade | ACCD | Mar 28, 2024 | 10.48 | +4.90 |
Accuray | ARAY | Mar 28, 2024 | 2.47 | +1.65 |
Ace Global Business Acquisition | ACBA | Mar 28, 2024 | 12.08 | +0.25 |
Ace Global Business Acquisition Unit | ACBAU | Mar 28, 2024 | 11.96 | 0.00 |
Acelyrin | SLRN | Mar 28, 2024 | 6.75 | 0.00 |
Achieve Life Sciences | ACHV | Mar 28, 2024 | 4.54 | +0.55 |
Achilles Therapeutics ADR | ACHL | Mar 28, 2024 | 1.25 | +5.04 |
ACI Worldwide | ACIW | Mar 28, 2024 | 33.21 | +2.06 |
Aclarion | ACON | Mar 28, 2024 | 0.33 | +1.23 |
Aclaris Therapeutics | ACRS | Mar 28, 2024 | 1.24 | -1.59 |
ACM Research A | ACMR | Mar 28, 2024 | 29.14 | +1.53 |
Acme United | ACU | Mar 28, 2024 | 46.99 | +1.89 |
ACNB | ACNB | Mar 28, 2024 | 37.60 | +1.92 |
Acorda Therapeutics | ACOR | Mar 28, 2024 | 13.21 | +10.92 |
ACRES Commercial Realty | ACR | Mar 28, 2024 | 14.06 | +2.93 |
ACRES Commercial Realty C Pref | ACR-C | Mar 28, 2024 | 24.12 | -3.52 |
ACRES Commercial Realty D Pref | ACR-D | Mar 28, 2024 | 21.51 | -5.62 |
Acrivon Therapeutics | ACRV | Mar 28, 2024 | 7.15 | +10.60 |
Actinium Pharmaceuticals | ATNM | Mar 28, 2024 | 7.83 | -1.39 |
Active Bear ETF | HDGE | Mar 28, 2024 | 19.60 | -0.33 |
Active U.S. Real Estate Powershares | PSR | Mar 28, 2024 | 88.15 | +0.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.